Founded in 1960, Kumho Tire was initially part of the Kumho Asiana Group and operated under the name Samyang Tire. However, in 2018, financial difficulties within the parent company led to ...

Gossamer Bio develops Seralutinib, which is basically an inhaled TKI that targets vascular remodeling, inflammation, and fibrosis. This makes it ideal for treating PAH and PH-ILD. GOSS has so far ...

GameSpot may get a commission from retail offers. Destiny is getting crossover content with one of the biggest sci-fi franchises on the planet, as Bungie has announced a partnership with Lucasfilm ...

ORLANDO, Fla.—The Masters Tournament is the first sign of spring for many northerners, frostbacks and frozen tundrists (a word I invented for your reading pleasure). The PGA Merchandise Show ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension ...

While there's been no confirmation of a Metal Gear Solid 6 on the horizon, it seems unlikely that Japanese entertainment giant Konami would abandon one of its most beloved properties so easily ...

Think retro-doused Harrington jackets, collegiate-inspired knitwear, geezer-y sweater vests, and clothing you can wear after a full 36 holes—and, more importantly, will actually want to.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

On 6 February, Kumho announced its 2024 performance forecast, with full-year revenue of 453.81 billion won (about ¥22.8 billion; £2.5 billion; €3 billion), a year-on-year increase of 12 per cent; and ...

Gossamer also reported encouraging preclinical data related to the combination of seralutinib and Winrevair. Gossamer Bio Inc. has released new data showing its inhaled kinase inhibitor, seralutinib, ...